New less invasive valve for failing mitral valve
Part of Heart & circulation clinical trials.
This trial tests a new, less invasive replacement valve for people whose mitral heart valve is failing. The goal is to improve blood flow and reduce symptoms like shortness of breath without the need for major open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a failing mitral valve (either a replacement that is no longer working or your own valve with a ring) that is significantly narrow or leaks moderately or more.
- Your heart structure is suitable for the new valve being tested.
- You have symptoms like shortness of breath or fatigue (at least class II) and are considered high-risk for traditional surgery.
- You do not have severe problems in other heart valves, severe heart muscle weakness, or conditions that would make the procedure unsafe.
- You have not had a recent heart attack, stroke, or infection of the heart lining within the last few months.
- You are not pregnant, do not have severe kidney failure, and can take blood-thinning medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, less invasive heart valve (Sutra Hemi-valve) for people with a leaky mitral valve who cannot have standard surgery. The valve is delivered through a vein in your leg, so you avoid open-heart surgery.
This trial studies a catheter-based procedure to replace the mitral valve in people with severe (or specific moderate) mitral valve leakage that causes symptoms. It may help by reducing leaking and related symptoms when standard surgery or less invasive fixes aren’t suitable for you.
This trial studies whether a new transcatheter aortic valve (SAPIEN X4) is safe and works well in people whose previously implanted aortic valve is now failing. It may help reduce valve symptoms in higher-surgery-risk patients who are not good candidates for open-heart valve replacement.
This trial tests a new version of a heart valve (SAPIEN X4) placed without open-heart surgery. It's for people with severe aortic stenosis who have symptoms like shortness of breath or chest pain.
This trial studies a new “valve-in-valve” procedure to treat a failing aortic bioprosthetic valve. It may help people improve blood flow through the heart valve and reduce valve-related problems.
This trial compares two different types of replacement heart valves for people whose previous surgical aortic valve has failed. Both valves are placed using a less invasive method (through a leg artery), and the study aims to see which option works better for this 'valve-in-valve' procedure.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.